THE GROWTH JOURNEY CONTINUES
JANUARY –
- Net sales increased by 54 percent (54 percent at constant exchange rates) and amounted to SEK 184.4 million (119.7).
- The
North America (NA) segment reported a sales growth of 65 percent (65 percent at constant exchange rate). - The
Europe & Rest of the World (EUROW) segment reported a sales growth of 27 percent (24 percent at constant exchange rates). - The gross margin amounted to 92.6 percent (90.5).
- The operating result before effects from the Group’s incentive programs amounted to
SEK 41.6 million (4.6). Reported operating result amounted toSEK 32.3 million (0.8). - Earnings per share before and after dilution were
SEK 0.33 (0.00).
"Successful regulatory milestones and continued strong growth."Emil Billbäck, CEO
EVENTS DURING THE REPORTING PERIOD
- In March, the FDA announced that CERAMENT BONE VOID FILLER has been approved for use in Spine Inter Body Fusion (IBF) in the US.
- In March, the FDA announced that CERAMENT G was approved for use in open fractures in the US.
EVENTS AFTER THE REPORTING PERIOD
- Nothing to report.
© Modular Finance, source